118 filings
10-K/A
2023 FY
TCBP
TC BioPharm (Holdings) plc
29 Apr 24
Annual report (amended)
5:23pm
8-K
TCBP
TC BioPharm (Holdings) plc
4 Apr 24
TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies
8:40am
10-K
2023 FY
TCBP
TC BioPharm (Holdings) plc
1 Apr 24
Annual report
5:11pm
8-K
TCBP
TC BioPharm (Holdings) plc
19 Mar 24
Submission of Matters to a Vote of Security Holders
8:00am
8-K
TCBP
TC BioPharm (Holdings) plc
18 Mar 24
Unregistered Sales of Equity Securities
8:00am
8-K
w59a4wvs hml
12 Mar 24
Unregistered Sales of Equity Securities
7:30am
8-K
su89wd 8u
6 Mar 24
Departure of Directors or Certain Officers
6:30am
DEF 14A
xqk9vbs57i7t iq16
20 Feb 24
Definitive proxy
6:05am
8-K
zr371an0rj9l4 gl0o
14 Feb 24
TCBP Provides Shareholder Update and Highlights Upcoming Milestones
2:48pm
PRE 14A
afywt3rywh6 i2j
9 Feb 24
Preliminary proxy
3:26pm
8-K
f6d2smkuesvg9yga
4 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:46am
6-K
brk5m2 2e3
21 Dec 23
TC BioPharm Announces Pricing of $3.5 Million Public Offering
5:14pm
424B4
h9ad1e tl
20 Dec 23
Prospectus supplement with pricing info
6:42pm
EFFECT
gngnuq1zpzg 3b2
19 Dec 23
Notice of effectiveness
12:15am
F-1/A
9iqpogzek414llb
14 Dec 23
Registration statement (foreign) (amended)
5:20pm
CORRESP
d36b vhgb
14 Dec 23
Correspondence with SEC
12:00am
6-K
0wubdv
13 Dec 23
TC BioPharm Announces Plan to Implement ADS Ratio Change
9:05am
F-1/A
pxxm7uc abj3ve
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
424B3
eyfdfon5kg20
8 Nov 23
Prospectus supplement
4:05pm
EFFECT
25jyrbu11bo9323a
7 Nov 23
Notice of effectiveness
12:15am